MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
Globenewswireยท2025-11-13 13:00
Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 202483% Growth in Year-Over-Year Revenue for International Medical CannabisInternational Medical sales now 56% of Total RevenueIncreased Cash Balance of $10.6 Million at the end of Q3 2025Operating Expenses Decreased 19% Year-Over-YearManagement to Host Conference Call / Webcast on November 13th, 2025 at 10:00 am ET TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" ...